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Abstract
Introduction and hypothesis We investigated the effect of
punicalagin (PUN; 2,3-hexahydroxydiphenoyl-gallagyl-D-
glucose), on mechanical-trauma-induced stress urinary incon-
tinence (SUI) in mouse and the mechanisms underlying any
effects.
Methods Ninety virgin female C57BL/6 mice were randomized
into six groups: five groups underwent vaginal distention (VD)
for 1 h and leak-point pressure (LPP) was measured on the 1st,
3rd, 7th, 14th, and 28th day following (VD groups 1 d, 3 d, 7 d,
14 d, and 28 d). The sixth group was a noninstrumented control
(NC) group. Then, 75 virgin female C57BL/6 mice were ran-
domized into five groups: a VD group (that just underwent VD)
and an NC group were orally administered saline every day for
7 days; and three VD + PUN groups that underwent VD and
were orally administered PUN respectively at 2.5, 5, and 10 mg/
kg every day for 7 days. LPP was tested on the day 7, then all
mice were sacrificed and their urethras and anterior vaginal walls
harvested for Masson staining, immunohistochemistry study,
Western blot analysis, and quantitative polymerase chain reaction
(qPCR).
Results LPPs after VD were significantly lower than the NC
group, and the LPPs of mice on days 14 and 28 day after VD
were significantly higher than on the days 1, 3, and 7. PUN
significantly improved VD-induced drops in LPP and alleviated
VD-induced decrease of collagen I, collagen III, α-smooth mus-
cle actin (SMA), transforming growth factor (TGF)-β1, and p-
Smad3, nuclear factor-erythroid 2 p45-related factor 2 (Nrf2),
and glutathione peroxidase (GPx1) protein levels, and increase
of 8-hydroxydeoxyguanosine (OHdG) in urethra and anterior
vaginal wall. PUN also up-regulated the expression of manga-
nese superoxide dismutase (MnSOD), whereas protein levels of
Smad 2, p-Smad2, and Smad3 were not changed.
Conclusions PUN exerts certain therapeutic effect on
mechanical-trauma-induced SUI in mice, which might be
through the activation of TGF-β1/Smad3 and Nrf2/antioxidant
response element (ARE) signaling activation.
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Introduction
Stress urinary incontinence (SUI) is a common social and
hygiene problem affecting the quality of life (QoL) of
25~57% adult women worldwide and causing serious social
economic load [1–5]. Although progress has been made in
treating SUI in recent decades, pharmacological therapy is
poorly understood. Therefore, drug discovery and develop-
ment for SUI is extremely urgent. The etiologic and patho-
physiologic mechanisms, however, have not been well eluci-
dated. Aging, vaginal childbirth, declined hormonal status
(menopause), and obesity were the main risk factors of SUI
[4–6]. Increasing research confirmed that mechanical-trauma-
induced oxidative damage and extracellular matrix (ECM)
remodeling are probably involved in the pathogenesis of
SUI, especially birth trauma and increased abdominal-
pressure-induced SUI or pelvic organ prolapase (POP) with
SUI [7–11]. Nuclear factor-erythroid 2 p45-related factor 2
(Nrf2) is an upstream transcription factor modulating
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antioxidant ability [12]. Upon oxidative stress, Nrf2 parts
from kelch-like ECH-associated protein 1 (Keap1) and trans-
locates into the nucleus to induce the expression of antioxidant
response elements (ARE), such as glutathione peroxidase
(GPx), superoxide dismutase (SOD), catalase (CAT), and
heme oxygenase (HO)-1, against oxidative damage [12].
Collagen is an important component in ECM and plays a
critical role in maintaining the normal functions of the pelvic
support structure. Previous studies demonstrated that inconti-
nence is associated with reduced content of collagen I, III, and
α-smooth muscle actin (SMA) [6, 13–17]. Transforming
growth factor β (TGF-β), including TGF-β1, TGF-β2, and
TGF-β3, a pleiotropic cytokine, plays important roles inmany
physiological and pathological processes; in mammals, the
primary factor is TGF-β1, and the TGF-β1/Smads pathway
plays an important role in the regulation of collagen
metabolism.
Accrding to the Chinese Compendium of Materia Medica,
pomegranate peel is used to treat archoptoma, dysentery,
hematockezia, morbid leucorrhoea, uterine bleeding, and
uroclepsia. Punicalagin (2,3-hexahydroxydiphenoyl-
gallagyl-D-glucose; PUN), the major bioactive component
of pomegranate peel, has antioxidant, anti-inflammatory, an-
tiviral, antiapoptosis, and anti-collagen-degradation properties
[18–20]. Previous studies demonstrated that PUN inhibits li-
popolysaccharide (LPS)-induced oxidative stress via upregu-
lation of the Nrf2/HO-1 pathway and alleviates oxidative
damage [18]. Additionally, PUN shows anti-collagen-
degradation activity in vitro [20]. In the work reported here,
we tested the hypothesis that PUN plays a role in treating
mechanical-stress-induced oxidative damage and ECM re-




Punicalagin [>98% high-performance liquid chromatography
(HPLC) purity] was purchased from Chengdu must Bio-tech
(Chengdu, China). Antibodies to β-actin (ab8227), collagen I
(ab21286), collagen III (ab7778), α-SMA (ab124964), Nrf2
(ab137550), TGF-β1 (ab92486), and GPx1 (ab22604) were
obtained from Abcam (Cambridge, UK). Antibodies to
Smad2 (5339p), Smad3 (9523p), p-Smad2 (3108p), and p-
Smad3 (9520p) were purchased from Cell Signaling
Technology (Danvers, MA, USA). Antibody to MnSOD
(06–984) was purchased from Millipore (Billerica, MA,
USA). Fluorescence-labeled secondary antibodies
(IRDye700 and IRDye800, goat antimouse/rabbit) was pur-
chased from Licor, Inc. (Lincoln, NE, USA).
Experimental animals and study design
Leak-point pressure (LPP) reflects the ability of urinary insis-
tence, hence the LPPs of mice in every group were measured
to determine the identification index of SUI in mice. In the
first part of this research, in order to investigate the efficiency
and duration of a vaginal distention (VD)-induced mouse
model of SUI, 90 wild-type virgin female C57BL/6 mice
(8~10 weeks old) were randomized into six groups: a
noninstrumented control (NC) group; and five groups
underwent VD for 1 h with 8-mm dilators (0.3 ml saline)
and their LPPs were measured respectively on days 1, 3, 7,
14, and 28 after VD (groups VD 1 d, 3 d, 7 d, 14 d, and 28 d).
There was no statistically significant difference among body
weights of mice between groups (Table 1). In the second part
of this research, to explore the potential therapeutic role of
PUN against VD-induced SUI and its underlying mechanism,
75 wild-type virgin female C57BL/6 mice (8~10 weeks old)
were randomized into five groups: NC, VD, and VD + PUN
2.5, 5, and 10. VD and VD + PUN 2.5, 5, and 10 mice
underwent VD for 1 h with 8-mm dilators the first day, then
the VD + PUN 2.5, 5, and 10 groups were orally administered
2.5, 5, and 10 mg/kg of PUN, respectively, every 24 h during
the entire experimental period. Mice in the NC and VD groups
were fed with equal amount of 0.9% normal saline. LPPs of
mice in all groups were measured on the day 7 after VD.
Animals were sacrificed, and urethras and anterior vaginal
walls were harvested for immunohistochemistry study,
Western blot analysis, and quantitative polymerase chain re-
action (qPCR). There was no statistically significant differ-
ence among body weight (Table 2). All experimental proto-
cols were approved by the Institutional Animal Care and Use
Committee of Renmin Hospital of Wuhan University.
Vaginal distention
Mice in the experimental groups underwent VD after being
anesthetizedwith urethane (1 g/kg, i.p.). After lubrication with
paraffin oil, a modified 6-F Foley catheter was inserted into
the vagina and secured to the vaginal introitus with a 5/0 silk
suture. Then, 0.3 ml distilled water was infused into the
Table 1 Body weights of mice in six groups x Sð Þ
Group Weight (g) F value P value
NC 16.04 ± 0.71 0.36 0.73
VD 1 d 16.20 ± 0.64
VD 3 d 15.97 ± 0.66
VD 7 d 16.23 ± 0.50
VD 14 d 16.05 ± 0.78
VD 28 d 16.17 ± 0.70
NC noninstrumented control, VD vaginal distention,
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balloon to distend the vagina. Each balloon’s diameter was
measured before VD using a Vernier caliper. After 1 h, the
balloonwas deflated and removed, and themouse permitted to
wake spontaneously. The NC group did not undergo VD.
Suprapubic tube implantation and LPP measurement
One day before LPP measurement, a epidural catheter
was implanted in the bladder under urethane (1 g/kg,
i.p.) anesthesia. On the day of LPP measurement, mice
were again anesthetized with urethane (1 g/kg, i.p.), the
bladder catheter was connected to both a micro syringe
pump and a pressure transducer of a urinary dynamics
detector (Nidoc970C, Weixin Medical of China) through
a T-branch pipe. Pressure and force transducer signals
were amplified and digitized for computer data collec-
tion. The bladder was then filled with room-temperature
saline at 1 ml/h through the bladder catheter. When half
the bladder capacity was reached, gentle pressure with
one finger was applied to the mouse’s abdomen.
Pressure was gently increased until urine leaked, at
which time the externally applied pressure was rapidly
removed. Peak bladder pressure was used as the LPP.
Voids could be easily distinguished from leaks. If a
mouse voided, the bladder was refilled and the process
was repeated. At least five LPPs were obtained on each
animal and the mean calculated.
Western blot
Total protein was extracted from specimens using
radioimmunoprecipitation assay (RIPA) buffer containing
phenylmethylsulfonyl fluoride (PMSF). Proteins were denatured
at 95 °C after concentration measurement, then 30μg of the total
protein was separated from these samples by 10% sodium dode-
cyl sulfate (SDS)–polyacrylamide gel electrophoresis (PAGE)
then transferred onto polyvinylidene fluoride (PVDF) mem-
branes. After being blocked, membranes were sequential blotted
with primary and secondary antibodies (1:10000). Signals were
detectedwith anOdyssey infrared imaging system (LI-CORBio,
USA). Primary antibodies were as follows: anti-Nrf2 (1:500),
anti-GPx1 (1:500), anti-MnSOD (1:500), anti-TGF-β1 (1:250),
anti-Smad2 (1:250), anti-p-Smad2 (1:250), anti-Smad3 (1:250),
anti-p-Smad3 (1:250), anticollagen I (1:100), anticollagen III
(1:250), anti-α-SMA (1:5000), and anti-tissue inhibitor of
metalloprotease (anti-TIMP-3) (1:1000).
Quantitative real-time polymerase chain reaction
Primers were purchased from Sangon Biotech (Shanghai,
China). Total RNA was extracted using RNAiso Plus
(TaKaRa Biotech, Dalian, China), and first-strand comple-
mentary (c) DNA was synthesized using a PrimeScriptTM
RT regent Kit (TaKaRa Biotech, Dalian, China). q-PCR was
conducted using SYBRR Premix Ex Taq™ II Kit (TaKaRa
Biotech, Dalian, China). SYBR green real-time PCR mix for
PCR containing 7.5 μM each of forward and reverse primers
(listed in Table 3). The reaction conditions were as follows:
predenaturation at 95 °C for 30 s; 40 cycles of 95 °C for 5 s,
and 60 °C for 34 s; then a final extension stage of 95 °C for
15 s, 60 °C for 1 min, and 95 °C for 15 s. β-actin was used as
the reference gene. Relative quantification of gene expression
for both target and reference genes was performed by the
2-ΔΔCt method and based on Ct values. Real-time PCR anal-
ysis results are presented as mean ± standard deviation (SD) of
fold change in expression.
Table 2 Body weights of mice in five groups x Sð Þ
Group Weight (g) F value P value
NC 16.10 ± 0.73 0.20 0.99
VD 16.03 ± 0.72
VD + PUN 2.5 15.97 ± 0.70
VD + PUN 5 16.13 ± 0.64
VD + PUN 10 15.95 ± 0.67
NC noninstrumented control, VD vaginal distention, PUN punicalagin
Table 3 Primers for quantitative
real-time polymerase chain
reaction
Gene name Gene ID Primer sequence (5′-3′) Amplicon size (bp)
Collagen I (A1) NM_007742.3 F: AAGAAGCACGTCTGGTTTGGAG 175
R: GGTCCATGTAGGCTACGCTGTT
Collagen III (A1) NM_009930 F: GTGGCAATGTAAAGAAGTCTCTGAAG 191
R: GGGTGCGATATCTATGATGGGTAG
α-SMA NM_031004.2 F: AACTGGTATTGTGCTGGACTCTG 172
R: CTCAGCAGTAGTCACGAAGGAATA
β-actin NM_007393.3 F: GTGACGTTGACATCCGTAAAGA 287
R: GTAACAGTCCGCCTAGAAGCAC
SMA smooth muscle actin
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Immunohistochemistry and Masson staining
All specimens were embedded in paraffin and cut into
4-μm-thick slices and fixed to glass slides. For immu-
nohistochemical staining, sections were deparaffinized in
xylene and rehydrated in a graded ethanol series.
Connective tissue was stained with Masson trichrome
( S i g m a , U S A ) f o l l o w i n g t h e p r o t o c o l .
I m m u n o h i s t o c h e m i c a l s t a i n i n g o f 8 -
hydroxydeoxyguanosine (8-OHdG) was performed fol-
lowing the protocol -(UltraSensitive™ S-P Kit, Maxim
Bio, China). As negative controls for immunohistochem-
istry analysis, sections were incubated with nonimmune
serum instead of the primary antibody and showed no
staining. Images were then analyzed with Image-Pro
Plus5.1.
Statistical analyses
All statistical analyses were performed with SPSS 21.0
(IBM Corporation, Armonk, NY, USA), and data are
presented as mean ± SD. Data were further subjected to
analysis of variance (ANOVA). Differences between two
groups were determined using Student’s t test, and mul-
tiple means were compared by Tukey’s test. P values <
0.05 were considered statistically significant.
Results
LPP decreased after VD and recovered over time
The VD induced SUI mouse model shows self-restoring ca-
pacity. In this study, as show in Table 4 and Fig. 1a, all LPPs
measured on days 1, 3, 7, 14, and 28 after VD were signifi-
cantly decreased when compared with the NC group. No sig-
nificant change was found on days 1, 3, and 7 after VD.
However, on the day 14 after VD, LPP was significantly
higher than on days 1, 3, and 7 and significantly lower than
on day 28 after VD. Therefore, VD-induced SUImouse model
stabilized 7 days after VD and recovered from day 14.
PUN promotes LPP recovery after VD in mice
Our preliminary result indicated that the VD-induced SUI
mouse model was stable 7 days after VD. Hence, we tested
LPPs of mice on day 7 after VD for more medication time.
Table 5 and Fig. 1b show LPPs of mice in five groups. LPPs
were significantly decreased in the VD and PUN 2.5, 5, and
10 groups compared with the NC group. Notably, treatment
with 5 and 10 mg/kg PUN after VD significantly increased
LPP; no significant change was found between PUN 2.5 and
VD groups.
Table 4 Leak-point pressure of mice in six groups x Sð Þ
Group LPP (cmH2O) 95% CI
NC 46.42 ± 6.30 (42.94–49.91)
VD 1 d 15.88 ± 7.07 (11.97–19.79)
VD 3 d 23.23 ± 5.46 (20.21–26.26)
VD 7 d 22.84 ± 6.58 (19.20–26.48)
VD 14 d 33.35 ± 9.60 (28.04–38.67)
VD 28 d 41.73 ± 12.73 (34.68–48.78)
NC noninstrumented control, VD vaginal distention, LPP leak-point pres-
sure, CI confidence interval
Fig. 1 Leak-point pressure (LPP) values: a Mice in vaginal distention
(VD) groups 1 d, 3 d, 7 d, 14 d, and 28 d were significantly lower than
those in noninstrumented control (NC) group, and LPP recovered from
the day 14 after VD. *P < 0.05 vs NC group; #P < 0.05 vs VD 1 d group;
&P < 0.05 vs VD 3 d group; $P < 0.05 vs VD 7 d group; ^P < 0.05 vs VD
14 d group. b LPP values of mice in VD, VD + punicalagin (PUN) 2.5,
VD + PUN 5, and VD + PUN 10 groups were significantly lower than the
NC group, whereas, values were significantly increased in VD + PUN 5
and VD + PUN 10 groups compared with the NC group. *P < 0.05 vs NC
group; #P < 0.05 compared with VD group. Every measurement was
repeated five times
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PUN prevents VD-induced metabolic disorder of ECM
in urethras and anterior vaginal wall of mice
Histologic examination of the midurethra showed typical
morphology of urethra and anterior vaginal wall
(Fig. 2a). Urethral muscle fibers were disrupted
(Fig. 2a) and connective tissues decreased in the VD
compared with the NC group (Fig. 2b). Connective tis-
sues in urethra and anterior vaginal wall were apparent-
ly increased in a dose-dependent manner in mice in the
VD + PUN group compared with the VD-alone group
(Fig. 2b). In addition, the results of Western blot and q-
PCR analysis (Fig. 3) show that both protein (Fig. 3a)
and messenger RNA (mRNA) (Fig. 3b) expression
Table 5 Leak-point pressure (LPP) of mice in five groups x Sð Þ
Group LPP (cmH2O) 95% CI
NC 48.17 ± 10.52 (42.34–54.00)
VD 22.19 ± 9.33 (17.02–27.36)
VD + PUN 2.5 25.73 ± 8.16 (21.21–30.25)
VD + PUN 5 31.16 ± 10.25 (25.48–36.84)
VD + PUN 10 33.16 ± 13.88 (25.47–40.85)
NC noninstrumented control, VD vaginal distention, PUN punicalagin,
LPP leak-point pressure, CI confidence interval
Fig. 2 Masson trichrome
staining of urethra and anterior
vaginal wall: a noninstrumented
control (NC) group (a–c), vaginal
distention (VD) group (d–f),
VD + punicalagin (PUN) 2.5
group (g–i), VD + PUN 5 group
(j–l), and VD + PUN 10 group
(m–p). Collagen fibers stained
blue, muscle white, cellulose and
cytoplasm red, nuclei blue-
purple. Second column:
magnification of the black
rectangle in the first column; third
column: magnification of the red
dotted rectangle in the first
column. Original magnification:
×100 (a, d, g, j, m); ×200 (b–c, e–
f, h–i, k–l, o–p). b
Semiquantitative assay of colla-
gen using quantity one-4.6.2.
*P < 0.05. Every experiment was
repeated three times
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levels of collagen I, collagen III, and α-SMA in urethra
and anterior vaginal wall were significantly decreased
after VD than those in the NC group. PUN increased
protein expression of collagen I, collagen III, and α-
SMA in a dose-dependent manner in VD + PUN mice
compared with VD alone.
PUN reverses VD-evoked TGFβ1/Smad3 signaling
inhibition in urethras and anterior vaginal wall of mice
TGF-β/Smads signaling plays an vital role in metabolism of
ECM and has been reported to have participated in the path-
ological process of mechanical-trauma-induced SUI. In this
study, results shown in Fig. 4 that expression levels of
TGF-β1 and p-Smad3 were significantly decreased after VD
compared with the NC group, but there were no significance
changes in Smad2, p-Smad2, and Smad3. Similarly, PUN
markedly increased TGF-β1 and p-Smad3 protein expression
in a dose-dependent manner in the urethra and anterior vaginal
wall after VD than in the NC group, with no significant effect
on protein expression of Smad2, p-Smad2, and Smad3.
PUN alleviates VD-induced oxidative damage in urethras
and anterior vaginal wall of mice through upregulation
of Nrf2/ARE signaling
To identify the involvement of Nrf2/ARE signaling activation
in PUN against mechanical-trauma-induced SUI, we detected
protein expression of Nrf2, GPx1, MnSOD, and the oxidative
damage biomarker 8-OHdG in mice. As shown in Fig. 5a,
expression levels of Nrf2 and GPx1 in urethra and anterior
vaginal wall were significantly decreased after VD than in
Fig. 3 Protein and messenger RNA (mRNA) expressions of collagen I,
collagen III, and α-smooth-muscle actin (SMA) in five groups. aWestern
blotting was performed to detect protein expression of collagen I,
collagen III, and α-SMA in urethra and anterior vaginal wall of mice in
five groups, and semiquantitative assay was done using quantity one-
4.6.2. b Messenger RNA (mRNA) expression of collagen I, collagen
III, and α-SMA in urethra and anterior vaginal wall of mice in five
groups were detected by quantitative polymerase chain reaction (q-
PCR). *P < 0.05 vs nonintrumented control (NC) group; #P < 0.05
compared with vaginal distention (VD) group; every experiment was
repeated three times
Fig. 4 Western blotting shows protein expressions of transforming
growth factor (TGF)-β1/Smads signaling pathways in urethra and
anterior vaginal wall of mice in five groups. Semiquantitative assay was
done using quantity one-4.6.2. *P < 0.05 compared with NC group;
#P < 0.05 compared with VD group. Every experiment was repeated
three times
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the NC group, and there was no significant difference in
MnSOD groups. In addition, PUN increased Nrf2, GPx1,
and MnSOD expression in a dose-dependent manner, and 8-
OHdG expressionwas significantly increased in the VD group
(Fig. 5b–c). However, 8-OHdG in PUN groups 5 and 10 were
significantly decreased compared with the VD group
(Fig. 5b–c).
Discussion
SUI is a common social and hygiene problem affecting the
QoL of women worldwide and causing serious social eco-
nomic load. Mechanical trauma, such as connective tissue,
muscle, or nerve, or damage to the vaginal wall or urethra
and its suspensory structures due to VD is a widely recognized
risk factor in the genesis of SUI. In addition, there are as yet no
drugs to effectively cure SUI. In this study, we used PUN to
reverse mechanical-trauma-induced SUI in a mouse model
and found it has a therapeutic role against mechanical-
trauma-induced decreases in LPP and metabolic disorders of
the ECM. This effect may be via TGF-β1/Smad3, and
Nrf2/ARE signaling activation.
VD is used to induce SUI in mice and rats, as evidenced by
LPP and/or maximal urethral closing pressure (MUCP) on
urodynamic testing [1, 8, 21, 22]. An SUI mouse model re-
vealed that a 0.3-ml intravaginal balloon (diameter ∼8 mm,
equal to brain-case diameter of newborn mice) produced
Fig. 5 Nuclear factor-erythroid 2 p45-related factor 2 (Nrf2)/antioxidant
response element (ARE) signaling-related proteins and 8-
hydroxydeoxyguanosine (8-OHdG) expression in five groups. a
Western blotting detected Nrf2, glutathione peroxidase (GPx1), and
manganese superoxide dismutase (MnSOD) in urethra and anterior
vaginal wall of mice in five groups. Semiquantitative assay was done
using quantity one-4.6.2. b Expression of 8-OHdG was detected using
immunohistochemistry in urethra and anterior vaginal wall;
representative images are shown: negative control (a–b);
noninstrumented control (NC) (c–d); vaginal dilation (VD) (e–f2); VD
+ punicalagin (PUN) 2.5 (g–h); VD + PUN 5 (i–j); VD + PUN 10 (k–l).
Images in the second column are magnification of the first column; the
images in the forth column are magnification of the third column. Scale =
50 μm. c Semiquantitative assay used Image-Pro Plus 5.1. *P < 0.05 cvs
#P < 0.05 vs VD. Every experiment was repeated three times
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greater LPP than 0.1- and 0.2-ml balloons [23]. VD-induced
SUI mouse model possesses self-restoring capacity [24, 25],
and LPP on measurements on days 0, 4, 10, and 20 after VD
showed that LPP was restored from day 20 [25].
In our study reported here, we measured LPP on days 1, 3,
7, 14, and 28 after VD. Seven days after VD, LPP was mark-
edly decreased from that of the NC group and began to recov-
er from day 14. Based on this result, we tested LPPs on day 7
following VD and PUN oral therapy. We found that PUN has
the potential to cure mechanical-trauma-induced SUI in mice
and report such findings here for the first time.
The vesical neck and urethra are attached to the anterior
vaginal wall, which has fascial connections to the levator ani
muscles through the arcus tendineus fasciae pelvis. In addi-
tion, connective tissue comprising collagen and elastin, as
well as muscle tissue, provides the vaginal wall with sufficient
strength and resilience to maintain normal anatomic position
and function. Pelvic floor injury (such as during childbirth)
may disrupt these supportive tissues and connections, causing
the urethra to lose its hammock-like support and resulting in
SUI [26]. In this study, urethral muscle fibers were disrupted,
connective tissue strength decreased, and both protein and
mRNA expressions of collagen I, collagen III, and α-SMA
decreased in urethra and the anterior vaginal wall after VD.
However, PUN significantly alleviated the metabolic disorder
of ECM. This may be due to the mechanism of PUN against
mechanical-trauma-induced SUI.
TGF-β1 signaling plays an important role in collagen and
α-SMA regulation.Studies show that TGF-β1 signaling is in-
volved in the pathological process of mechanical-trauma-
induced SUI [27–29]. In addition, TGF-β1 expression in
uterosacral ligaments of women with POP and SUI was de-
creased compared with women with POP only or in the con-
trol group [15]. To determine whether TGF-β1 signaling is
involved in PUN-induced increase in ECM after VD, we
assessed changes in TGF-β1 signaling in the mouse urethra
and anterior vaginal. Our results show that the protein expres-
sion levels of TGF-β1 and p-Smad3 in the VD group were
significantly down-regulated compared with the NC group,
with no significant difference in Smad2, p-Smad2, and
Smad3 expression, whereas PUN activated VD-induced
TGF-β1/Smad3 signaling inhibition. One study indicated that
TGF-β1 and p-Smad2 expression was up-regulated in urethral
tissue of SUI rats and not in the sham group [29]. Another
study found that Smad7 expression decreased and Smad3 in-
creased in urethral tissue of SUI rats vs the control group [28].
However, those studies measured TGF-β signaling 4 weeks
after VD; our results show that the LPP began to recover from
day 14. We tested TGF-β signaling on day 7 also, which
showed early-phase changes in TGF-β signaling in both ure-
thra and anterior vaginal wall of our mouse model, whereas
the rat models reflect the later-phase changes in urethral tis-
sues. Hence, we deduce that TGF-β signaling was inhibited in
the early phase and activated in the later phase of our study. In
addition, changes in Smad3 were antecedent to Smad2. As a
result, LPP was decreased in the early phase and gradually
recovered in the later phase of recovery from VD. As a con-
sequence, TGF-β signaling may be an important target for
preventing and treating SUI.
Oxidative damage to vaginal wall and urethral sphincter
was confirmed as a result of mechanical trauma and was
prominent in the pathological process of pelvic floor dysfunc-
tion (PFD) [7–11]. Previous study indicated that cyclic me-
chanical strain increased oxidative damage to human
parametrial ligament fibroblasts and may be a pathogenesis
of PFD [30]. A recent study showed that H2O2 significantly
decreased the contractile force of isolated strips of bladder and
bladder-base urethra [11]. PUN, as a type of antioxidant, has
shown to alleviate oxidative damage both in vivo and in vitro
by upregulating Nrf2/ARE signaling pathway.
In this study, protein expressions of Nrf2 and its down-
stream GPx1 were significantly decreased in VD mice, and
oxidative damage aggravated the urethra and anterior vaginal
wall. However, PUN up-regulated expressions of antioxidant
proteins Nrf2 and GPx1 and alleviated VD-induced oxidative
damage to the urethra and anterior vaginal wall. Hence,
mechanical-trauma-induced decrease in antioxidant capacity
and increase in oxidative damage to urethra and anterior vag-
inal wall may be the pathogenesis of a metabolic disorder of
the ECM and result in SUI. Therefore, the oxidation–antiox-
idation system may be an important target for SUI prevention
and treatment. Some antioxidant foods or drugs may have
beneficial protective effects against mechanical-trauma-
induced SUI.
In conclusion, our results suggest that mechanical-trauma-
induced VD can cause SUI in female mice, recovery begins at
day 14. In the early phase after VD, direct disruption of the
urethral structure and TGF-β1/Smad3 and Nrf2/ARE signal-
ing inhibition induced a metabolic disorder in the ECM. .
PUN had certain therapeutic effects on mechanical-trauma-
induced SUI by up-regulating Nrf2/ARE and TGF-β1/
Smad3 pathways. However, further research is needed to con-
firm the relationship between these two signaling processes in
the pathogenesis of mechanical-trauma-induced SUI.
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